Home » Topics » Regulatory

Regulatory
RSS

FDA approves Vizimpro for first-line treatment of metastatic NSCLC with EGFR mutations

Sep. 28, 2018

FDA approves Emgality for preventive treatment of migraine in adults

Sep. 28, 2018

European Commission approves pegfilgrastim biosimilar Udenyca

Sep. 26, 2018

FDA grants approval for Copiktra for CLL/SLL, accelerated approval in follicular lymphoma

Sep. 25, 2018

Xospata approved in Japan for FLT3 mutation-positive relapsed or refractory AML

Sep. 25, 2018

Beova granted marketing approval in Japan for overactive bladder

Sep. 25, 2018

Eybelis granted marketing approval for glaucoma and ocular hypertension in Japan

Sep. 25, 2018

Lorlatinib receives first approval in Japan

Sep. 21, 2018

Hulio, a biosimilar to adalimumab, receives marketing authorization in Europe

Sep. 21, 2018

FDA approves Ajovy for preventive treatment of migraine

Sep. 17, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for June 5, 2025.
Highridge sells bone healing business to Avista
BioWorld MedTech
In the midst of June’s peak wedding season, Highridge Medical LLC called it splitsville – selling its bone healing division to Avista Healthcare Partners. The...
Pharma execs speak out: UK pricing rebates scare investors
BioWorld
The row between pharma companies and the U.K. government over rebates has intensified, with the Association of the British Pharmaceutical Industry calling up its...
Regenxbio’s Duchenne gene therapy data positive as shares falter
BioWorld
Regenxbio Inc.’s gene therapy in treating Duchenne muscular dystrophy (DMD) produced positive initial phase I/II results from its first five patients. However,...